225 related articles for article (PubMed ID: 24316427)
1. Sensitive derivatization methods for the determination of genotoxic impurities in drug substances using hyphenated techniques.
Raman NV; Prasad AV; Reddy KR
J Pharm Biomed Anal; 2014 Feb; 89():276-81. PubMed ID: 24316427
[TBL] [Abstract][Full Text] [Related]
2. A critical review on the use of modern sophisticated hyphenated tools in the characterization of impurities and degradation products.
Singh S; Handa T; Narayanam M; Sahu A; Junwal M; Shah RP
J Pharm Biomed Anal; 2012 Oct; 69():148-73. PubMed ID: 22521633
[TBL] [Abstract][Full Text] [Related]
3. A practical derivatization LC/MS approach for determination of trace level alkyl sulfonates and dialkyl sulfates genotoxic impurities in drug substances.
An J; Sun M; Bai L; Chen T; Liu DQ; Kord A
J Pharm Biomed Anal; 2008 Nov; 48(3):1006-10. PubMed ID: 18687555
[TBL] [Abstract][Full Text] [Related]
4. Determination of arylamines and aminopyridines in pharmaceutical products using in-situ derivatization and liquid chromatography-mass spectrometry.
Vanhoenacker G; Dumont E; David F; Baker A; Sandra P
J Chromatogr A; 2009 Apr; 1216(16):3563-70. PubMed ID: 18804773
[TBL] [Abstract][Full Text] [Related]
5. Eliminating pharmaceutical impurities: Recent advances in detection techniques.
Liu DQ; Sun M; Wu L
Curr Opin Drug Discov Devel; 2010; 13(6):748-57. PubMed ID: 21061235
[TBL] [Abstract][Full Text] [Related]
6. Applications of hyphenated LC-MS techniques in pharmaceutical analysis.
Ermer J; Vogel M
Biomed Chromatogr; 2000 Oct; 14(6):373-83. PubMed ID: 11002275
[TBL] [Abstract][Full Text] [Related]
7. Forced degradation and impurity profiling: recent trends in analytical perspectives.
Jain D; Basniwal PK
J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
[TBL] [Abstract][Full Text] [Related]
8. Assay at low ppm level of dimethyl sulfate in starting materials for API synthesis using derivatization in ionic liquid media and LC-MS.
Grinberg N; Albu F; Fandrick K; Iorgulescu E; Medvedovici A
J Pharm Biomed Anal; 2013 Mar; 75():1-6. PubMed ID: 23312378
[TBL] [Abstract][Full Text] [Related]
9. Control and analysis of alkyl and benzyl halides and other related reactive organohalides as potential genotoxic impurities in active pharmaceutical ingredients (APIs).
Elder DP; Lipczynski AM; Teasdale A
J Pharm Biomed Anal; 2008 Nov; 48(3):497-507. PubMed ID: 18657926
[TBL] [Abstract][Full Text] [Related]
10. Identification of pharmaceutical impurities in formulated dosage forms.
Pan C; Liu F; Motto M
J Pharm Sci; 2011 Apr; 100(4):1228-59. PubMed ID: 24081463
[TBL] [Abstract][Full Text] [Related]
11. The use of LC/MS, GC/MS, and LC/NMR hyphenated techniques to identify a drug degradation product in pharmaceutical development.
Pan C; Liu F; Ji Q; Wang W; Drinkwater D; Vivilecchia R
J Pharm Biomed Anal; 2006 Feb; 40(3):581-90. PubMed ID: 16242883
[TBL] [Abstract][Full Text] [Related]
12. Analysis of unknown compounds in azithromycin bulk samples with liquid chromatography coupled to ion trap mass spectrometry.
Debremaeker D; Visky D; Chepkwony HK; Van Schepdael A; Roets E; Hoogmartens J
Rapid Commun Mass Spectrom; 2003; 17(4):342-50. PubMed ID: 12569445
[TBL] [Abstract][Full Text] [Related]
13. A selective and sensitive UPLC-MS/MS approach for trace level quantification of four potential genotoxic impurities in zolmitriptan drug substance.
Vijaya Bhaskar Reddy A; Venugopal N; Madhavi G; Gangadhara Reddy K; Madhavi V
J Pharm Biomed Anal; 2013 Oct; 84():84-9. PubMed ID: 23816589
[TBL] [Abstract][Full Text] [Related]
14. A new liquid chromatography-mass spectrometry approach for generic screening and quantitation of potential genotoxic alkylation compounds without derivatization.
Cappiello A; Famiglini G; Palma P; Termopoli V; Trufelli H
J Chromatogr A; 2012 Sep; 1255():286-90. PubMed ID: 22226454
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a sensitive method for alkyl sulfonate genotoxic impurities determination in drug substances using gas chromatography coupled to triple quadrupole mass spectrometry.
Liu Z; Fan H; Zhou Y; Qian X; Tu J; Chen B; Duan G
J Pharm Biomed Anal; 2019 May; 168():23-29. PubMed ID: 30784886
[TBL] [Abstract][Full Text] [Related]
16. Chemical derivatization and mass spectral libraries in metabolic profiling by GC/MS and LC/MS/MS.
Halket JM; Waterman D; Przyborowska AM; Patel RK; Fraser PD; Bramley PM
J Exp Bot; 2005 Jan; 56(410):219-43. PubMed ID: 15618298
[TBL] [Abstract][Full Text] [Related]
17. Functional group-specific multilateral derivatization cum extraction method for simultaneous quantification of genotoxic impurities in carvedilol phosphate drug using GC-MS and their toxicity assessments.
Elumalai S; Thenmozhi K; Senthilkumar S; Sabarinathan S; Ponnusamy VK
J Pharm Biomed Anal; 2022 Oct; 220():114974. PubMed ID: 35963020
[TBL] [Abstract][Full Text] [Related]
18. Strategies for the identification, control and determination of genotoxic impurities in drug substances: a pharmaceutical industry perspective.
Raman NV; Prasad AV; Ratnakar Reddy K
J Pharm Biomed Anal; 2011 Jun; 55(4):662-7. PubMed ID: 21193280
[TBL] [Abstract][Full Text] [Related]
19. Trace determination of mutagenic alkyl toluenesulfonate impurities via derivatization headspace-GC/MS in an active pharmaceutical ingredient of a candidate drug.
Liu XW; Zhang WP; Han HY; Sun L; Chen DY
J Pharm Biomed Anal; 2018 Jun; 155():104-108. PubMed ID: 29626717
[TBL] [Abstract][Full Text] [Related]
20. Analytical control of genotoxic impurities in the pazopanib hydrochloride manufacturing process.
Liu DQ; Chen TK; McGuire MA; Kord AS
J Pharm Biomed Anal; 2009 Sep; 50(2):144-50. PubMed ID: 19427156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
